OpenLB
Open Library of Bioscience
Advanced Search
Antimicrobial agents and chemotherapy
04 18, 2023;67 (4): e0136822.

Emergence of Canonical and Noncanonical Genomic Variants following Exposure of Clinical Mycobacterium tuberculosis Strains to Bedaquiline or Clofazimine.

N Ismail, A Dippenaar, R M Warren, R P H Peters, S V Omar
Author Information
  1. N Ismail: SAMRC Centre for Tuberculosis Research/DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa. ORCID
  2. A Dippenaar: Global Health Institute, Department of Family Medicine and Population Health, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium. ORCID
  3. R M Warren: SAMRC Centre for Tuberculosis Research/DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
  4. R P H Peters: Department of Medical Microbiology, Faculty of Health Sciences, University of Pretoria, Prinshof, Gauteng, South Africa.
  5. S V Omar: Department of Medical Microbiology, School CAPHRI (Care and Public Health Research Institute), Maastricht University, Maastricht, The Netherlands.
PMID: 36892309 DOI: 10.1128/aac.01368-22

Abstract

In Mycobacterium tuberculosis, bedaquiline and clofazimine resistance occurs primarily through variants, a gene encoding a repressor protein that regulates / efflux pump gene expression. Despite the shared effect of both drugs on efflux, little else is known about other pathways affected. We hypothesized that generation of bedaquiline- or clofazimine-resistant mutants could provide insight into additional mechanisms of action. We performed whole-genome sequencing and determined phenotypic MICs for both drugs on progenitor and mutant progenies. Mutants were induced through serial passage on increasing concentrations of bedaquiline or clofazimine. variants were identified in both clofazimine- and bedaquiline-resistant mutants, with concurrent SNPs occurring in the latter. Of concern was the acquisition of variants in the F420 biosynthesis pathway in clofazimine-resistant mutants obtained from either a fully susceptible (: del555GCT) or rifampicin mono-resistant (: 283delTG and T862C) progenitor. The acquisition of these variants possibly implicates a shared pathway between clofazimine and nitroimidazoles. Pathways associated with drug tolerance and persistence, F420 biosynthesis, glycerol uptake and metabolism, efflux, and NADH homeostasis appear to be affected following exposure to these drugs. Shared genes affected by both drugs include , , , and . Genes with variants in the bedaquiline resistant mutants included , , , , , and , while clofazimine-resistant mutants displayed , , , , , , and variants. These results show the importance of epistatic mechanisms as a means of responding to drug pressure and highlight the complexity of resistance acquisition in M. tuberculosis.

Keywords

Mycobacterium tuberculosis bedaquiline canonical clofazimine genetic signatures in vitro mutants noncanonical variants resistance

References

  1. Lancet Microbe. 2020 Aug;1(4):e139-e140 [PMID: 35544268]
  2. PLoS One. 2014 Jul 10;9(7):e102135 [PMID: 25010492]
  3. Nat Commun. 2019 Oct 31;10(1):4970 [PMID: 31672993]
  4. Nature. 2001 Feb 22;409(6823):1007-11 [PMID: 11234002]
  5. J Microbiol Methods. 2018 Oct;153:1-9 [PMID: 30165087]
  6. Antimicrob Agents Chemother. 2019 Jul 25;63(8): [PMID: 31138569]
  7. Afr J Lab Med. 2019 Feb 21;8(1):801 [PMID: 30863717]
  8. Lancet Microbe. 2021 Nov;2(11):e604-e616 [PMID: 34796339]
  9. Data Brief. 2018 Sep 24;20:1975-1983 [PMID: 30306102]
  10. Lancet Microbe. 2020 Aug;1(4):e165-e174 [PMID: 32803174]
  11. Methods Mol Biol. 2009;465:173-86 [PMID: 20560078]
  12. Genome Med. 2015 May 27;7(1):51 [PMID: 26019726]
  13. PLoS Pathog. 2007 Jul;3(7):e110 [PMID: 17658950]
  14. Proc Natl Acad Sci U S A. 2019 Sep 24;116(39):19665-19674 [PMID: 31488707]
  15. Bioinformatics. 2009 Jul 15;25(14):1754-60 [PMID: 19451168]
  16. Tuberculosis (Edinb). 2018 Jan;108:186-194 [PMID: 29523322]
  17. Proc Natl Acad Sci U S A. 2018 Feb 13;115(7):1599-1604 [PMID: 29382761]
  18. J Biol Chem. 2008 Apr 25;283(17):11832-40 [PMID: 18252724]
  19. Proc Natl Acad Sci U S A. 2020 Feb 25;117(8):3910-3912 [PMID: 32075922]
  20. Eur Respir J. 2020 Jun 4;55(6): [PMID: 32060065]
  21. Nat Commun. 2019 Apr 5;10(1):1558 [PMID: 30952857]
  22. J Antimicrob Chemother. 2015 Sep;70(9):2507-10 [PMID: 26045528]
  23. Nat Commun. 2016 Aug 10;7:12393 [PMID: 27506290]
  24. Genome Res. 2010 Sep;20(9):1297-303 [PMID: 20644199]
  25. Bioinformatics. 2014 Aug 1;30(15):2114-20 [PMID: 24695404]
  26. J Biol Chem. 2011 Mar 25;286(12):10276-87 [PMID: 21193400]
  27. Sci Rep. 2021 Sep 30;11(1):19431 [PMID: 34593898]
  28. Nat Commun. 2023 Mar 18;14(1):1517 [PMID: 36934122]
  29. J Antimicrob Chemother. 2017 Mar 1;72(3):684-690 [PMID: 28031270]
  30. J Bacteriol. 2012 Jun;194(11):2916-23 [PMID: 22467787]
  31. Infect Genet Evol. 2019 Nov;75:103948 [PMID: 31276801]
  32. Antimicrob Agents Chemother. 2020 Dec 16;65(1): [PMID: 33077652]
  33. Braz J Microbiol. 2010 Apr;41(2):300-3 [PMID: 24031495]
  34. Antimicrob Agents Chemother. 2019 Feb 26;63(3): [PMID: 30642938]
  35. J Antimicrob Chemother. 2020 Aug 1;75(8):2031-2043 [PMID: 32361756]
  36. Genome Med. 2019 Jun 24;11(1):41 [PMID: 31234910]
  37. Antimicrob Agents Chemother. 2016 Jul 22;60(8):4590-9 [PMID: 27185800]
  38. Tuberculosis (Edinb). 2018 Jul;111:31-34 [PMID: 30029911]
  39. Bioinformatics. 2009 Aug 15;25(16):2078-9 [PMID: 19505943]
  40. Front Cell Infect Microbiol. 2021 Jan 11;10:611683 [PMID: 33505923]
  41. J Bacteriol. 2001 Dec;183(24):7058-66 [PMID: 11717263]

MeSH Term

Humans
Clofazimine
Mycobacterium tuberculosis
Antitubercular Agents
Diarylquinolines
Microbial Sensitivity Tests
Genomics
Tuberculosis, Multidrug-Resistant

Chemicals

Clofazimine
bedaquiline
Antitubercular Agents
Diarylquinolines
Journal Article Research Support, Non-U.S. Gov't
Article has an altmetric score of 1

Word Cloud

Created with Highcharts 10.0.0variantsmutantstuberculosisbedaquilineclofaziminedrugsMycobacteriumresistanceeffluxaffectedclofazimine-resistantacquisitiongenesharedmechanismsprogenitorF420biosynthesispathway:drugfollowingoccursprimarilyencodingrepressorproteinregulates/pumpexpressionDespiteeffectlittleelseknownpathwayshypothesizedgenerationbedaquiline-provideinsightadditionalactionperformedwhole-genomesequencingdeterminedphenotypicMICsmutantprogeniesMutantsinducedserialpassageincreasingconcentrationsidentifiedclofazimine-bedaquiline-resistantconcurrentSNPsoccurringlatterconcernobtainedeitherfullysusceptibledel555GCTrifampicinmono-resistant283delTGT862CpossiblyimplicatesnitroimidazolesPathwaysassociatedtolerancepersistenceglyceroluptakemetabolismNADHhomeostasisappearexposureSharedgenesincludeGenesresistantincludeddisplayedresultsshowimportanceepistaticmeansrespondingpressurehighlightcomplexityMEmergenceCanonicalNoncanonicalGenomicVariantsExposureClinicalStrainsBedaquilineClofaziminecanonicalgeneticsignaturesvitrononcanonical

Similar Articles

Cited By